1114 related articles for article (PubMed ID: 24512909)
1. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.
Panaccione R; Ghosh S; Middleton S; Márquez JR; Scott BB; Flint L; van Hoogstraten HJ; Chen AC; Zheng H; Danese S; Rutgeerts P
Gastroenterology; 2014 Feb; 146(2):392-400.e3. PubMed ID: 24512909
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Rutgeerts P;
Gastroenterology; 2014 Jan; 146(1):96-109.e1. PubMed ID: 23770005
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ; van Assche G; Reinisch W; Colombel JF; D'Haens G; Wolf DC; Kron M; Tighe MB; Lazar A; Thakkar RB
Gastroenterology; 2012 Feb; 142(2):257-65.e1-3. PubMed ID: 22062358
[TBL] [Abstract][Full Text] [Related]
6. Predictors of tissue healing in ulcerative colitis patients treated with anti-TNF.
Viazis N; Giakoumis M; Bamias G; Goukos D; Koukouratos T; Katopodi K; Karatzas P; Triantos C; Tsolias C; Theocharis G; Daikos GL; Ladas SD; Karamanolis DG; Mantzaris GJ
Dig Liver Dis; 2017 Jan; 49(1):29-33. PubMed ID: 27866814
[TBL] [Abstract][Full Text] [Related]
7. [Ulcerative colitis: Infliximab-Azathioprine combination therapy is superior to monotherapy].
Storr M
Med Monatsschr Pharm; 2014 Dec; 37(12):470-1. PubMed ID: 25643453
[No Abstract] [Full Text] [Related]
8. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus.
Tsukamoto H; Tanida S; Mizoshita T; Ozeki K; Ebi M; Shimura T; Mori Y; Kataoka H; Kamiya T; Joh T
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):714-8. PubMed ID: 23411870
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective study.
Lee KM; Jeen YT; Cho JY; Lee CK; Koo JS; Park DI; Im JP; Park SJ; Kim YS; Kim TO; Lee SH; Jang BI; Kim JW; Park YS; Kim ES; Choi CH; Kim HJ;
J Gastroenterol Hepatol; 2013 Dec; 28(12):1829-33. PubMed ID: 23829336
[TBL] [Abstract][Full Text] [Related]
10. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M;
Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316
[TBL] [Abstract][Full Text] [Related]
11. Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis.
De Vos M; Dewit O; D'Haens G; Baert F; Fontaine F; Vermeire S; Franchimont D; Moreels T; Staessen D; Terriere L; Vander Cruyssen B; Louis E;
J Crohns Colitis; 2012 Jun; 6(5):557-62. PubMed ID: 22398050
[TBL] [Abstract][Full Text] [Related]
12. Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis.
Hyams J; Damaraju L; Blank M; Johanns J; Guzzo C; Winter HS; Kugathasan S; Cohen S; Markowitz J; Escher JC; Veereman-Wauters G; Crandall W; Baldassano R; Griffiths A;
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):391-9.e1. PubMed ID: 22155755
[TBL] [Abstract][Full Text] [Related]
13. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
14. Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.
Cucchiara S; Romeo E; Viola F; Cottone M; Fontana M; Lombardi G; Rutigliano V; de'Angelis GL; Federici T
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S260-4. PubMed ID: 18598998
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
[TBL] [Abstract][Full Text] [Related]
16. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
18. Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis.
Sands BE; Sandborn WJ; Creed TJ; Dayan CM; Dhanda AD; Van Assche GA; Greguš M; Sood A; Choudhuri G; Stempien MJ; Levitt D; Probert CS
Gastroenterology; 2012 Aug; 143(2):356-64.e1. PubMed ID: 22549092
[TBL] [Abstract][Full Text] [Related]
19. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
[TBL] [Abstract][Full Text] [Related]
20. The long-term efficacy of azathioprine in steroid-dependent ulcerative colitis.
Park SK; Yang SK; Ye BD; Kim KJ; Yang DH; Jung KW; Park SH; Kim JW; Byeon JS; Myung SJ; Kim JH
Scand J Gastroenterol; 2013 Dec; 48(12):1386-93. PubMed ID: 24164382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
